Le Lézard
Classified in: Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Everest Re Group to Hold Fourth Quarter 2022 Earnings Conference Call on Thursday, February 9, 2023


Everest Re Group, Ltd. ("Everest") (NYSE: RE) will hold its fourth quarter 2022 earnings conference call on Thursday, February 9, 2023, beginning at 8:00 am Eastern Time.

Dial in details can be obtained by completing the registration form available at: https://dpregister.com/sreg/10173618/f53de1bfca

The call can be accessed via a live, listen only webcast at www.everestre.com/Investors, where a replay of the call will also be available.

Everest will release financial results on February 8, 2023 after the NYSE market close. At that time, Everest's earnings release and financial supplement will be made available at www.everestre.com/Investors.

About Everest

Everest is a global underwriting leader providing best-in-class property, casualty, and specialty reinsurance and insurance solutions that address customers' most pressing challenges. Known for a 50-year track record of disciplined underwriting, capital and risk management, Everest, through its global operating affiliates, is committed to underwriting opportunity for colleagues, customers, shareholders, and communities worldwide.

Everest common stock (NYSE: RE) is a component of the S&P 500 index.

Additional information about Everest, our people, and our products can be found on our website at www.everestre.com.


These press releases may also interest you

at 19:35
Regenx Tech Corp., (the "Company" or "Regenx") is providing this bi-weekly update on the status of the application to the Alberta Securities Commission for a management cease trade order, under National Policy 12-203 -?? Management Cease Trade...

at 19:14
Kadestone Capital Corp. ("Kadestone" or the "Company") , a vertically integrated property company today announced its financial results for the year ended December 31, 2023....

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:54
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Autodesk, Inc. ("Autodesk" or "the Company") and certain of its officers....

at 18:54
Cliffside Capital Ltd. ("Cliffside" or the "Company")  is pleased to announce financial results for the year ended December 31, 2023. The Company reported the following for 2023 compared with the prior year: Decline in gross finance receivables by...



News published on and distributed by: